Wound Debridement Markets to 2023: Lucrative Opportunities for New Entrants - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 3, 2018--The “Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The global wound debridement market is expected to reach USD 1,041 Million by 2023 from USD 702 Million in 2018, at a CAGR of 8.2%.
The global wound debridement market has been segmented by product. Gels accounted for the largest share of the market in 2017. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of gels.
Based on wound type, the VLUs segment is expected to offer growth opportunities for market players during the forecast period, primarily due to the growing patient pool for the condition. Apart from this, the DFUs segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing prevalence of diabetes globally.
Based on end user, in 2018, the hospitals segment is estimated to account for the largest market share. The availability of infrastructure and the presence of skilled professionals in hospitals are the major driving factors for this segment.
Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mlnlycke Health Care AB (Sweden), and Integra LifeSciences (US) have been identified as key players in this market. These companies have broad product portfolios with comprehensive features. These leaders also have products for all end users in this market, a strong geographical presence, and a focus on continuous product innovation.
DriversRising Incidence of Diabetes and Associated Wounds Growth in the Aging Population Rising Incidence of Burn Injuries Awareness Programs for Wound Care Treatment and Management
OpportunitiesLucrative Opportunities for New Entrants Growth Potential of Emerging Economies
TrendsFocus on Autolytic Debridement & Disposable Products
Companies ProfiledB. Braun Melsungen AG Coloplast Convatec Group Deroyal Industries Integra Lifesciences Lohmann & Rauscher Medline Industries Misonix Mlnlycke Health Care AB Smith & Nephew Welcare Industries
For more information about this report visit https://www.researchandmarkets.com/research/r8zmx7/wound_debridement?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181003005397/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Wound Care
INDUSTRY KEYWORD: SURGERY HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/03/2018 06:39 AM/DISC: 10/03/2018 06:39 AM